Literature DB >> 6205822

High-frequency jet ventilation versus conventional ventilation after surfactant displacement in dogs.

B S Kumar, K Beney, M Jastremski, G Nieman, C Bredenberg.   

Abstract

High-frequency jet ventilation (HFJV) was compared with conventional ventilation (CV) after surfactant displacement with diocytyl sodium sulfosuccinate (OT) via ultrasonic nebulization. After aerosol delivery, dogs were separated into 3 groups and followed for 2 h. Ventilator settings were not changed in group I (CV) and group II (HFJV) after OT delivery. In group III, drive pressure was increased to 40 psi. Adequacy of oxygenation varied directly with peak inspiratory pressure (PIP) rather than airway pressure (Paw) in both HFJV and CV. In all groups, immediately after OT administration PaO2 decreased and there was a slight increase in Paw; PIP was significantly elevated only in groups I and III. Two hours later, PaO2 had returned to baseline in groups I and III, but had not improved significantly in group II. Paw remained the same in all groups. These data demonstrate that in noncompliant lungs, oxygenation is not improved unless a high PIP is used to establish the critical opening pressures needed to rerecruit alveoli. In this noncompliant lung model, HFJV was not effective at low Paw values, and thus offered no apparent advantage over CV.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205822     DOI: 10.1097/00003246-198409000-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  2 in total

1.  Pneumomediastinum due to high-frequency jet ventilation in a near-drowned infant.

Authors:  M Aibiki; Y Shirakawa; K Ogli; T Uefuji; Y Tosaki; S Yokono; H Komatsu; A Yokono
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

2.  Prophylactic use of high-frequency percussive ventilation in patients with inhalation injury.

Authors:  W G Cioffi; L W Rue; T A Graves; W F McManus; A D Mason; B A Pruitt
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.